Learn

Historic Move Could Transform Psilocybin Access for Terminally Ill Patients

The DEA requested that federal health officials conduct a medical review of psilocybin - a watershed moment for psychedelic medicine.

Read More

VA Expands Psychedelic Therapy Trials for Veterans with PTSD

The VA has confirmed an expansion of psychedelic assisted therapy trials for veterans with PTSD, treatment resistant depression, and anxiety.

Read More

Colorado Poised to Become First State to Offer Regulated Ibogaine Therapy

Colorado regulators are reviewing rules that could add ibogaine to the state's Natural Medicine program -- making it the first

Read More

How Psychedelic Therapy Is Changing PTSD Treatment in 2026

MDMA, psilocybin, and ketamine are transforming PTSD treatment. See the latest trial data, VA programs, state access, and what's available

Read More

5 Best Ketamine Clinics in Kansas City (2026) — Verified & Reviewed

The 5 best ketamine clinics in Kansas City (2026), verified for pioneer ketamine psychiatry, multimodal interventional stack, and pricing —

Read More

3 Best Ketamine Clinics in Northern Colorado (2026) — Verified & Reviewed

The 3 best ketamine clinics in Northern Colorado (2026), verified for KAP integration, multidisciplinary integrative-psychiatry team at Wholeness Center, and

Read More

Definium’s Phase 3 LSD Drug Clears a Major Depression Test

Definium Therapeutics LSD based pill, DT120 ODT, reduced depression symptoms in a phase 3 trial of adults with major depressive

Read More

What a Ketamine Infusion Costs in 2026: Every Posted Price in Our Directory, Analyzed

The national median price of a ketamine infusion in 2026 is $400. That number comes from our own directory. We

Read More

As Psychedelic Care Gets Leaner, the Integration Work Moves Home. Our Data Says Home Is a Coin Flip

A new Canadian Journal of Psychiatry paper argues leaner psychedelic protocols displace integration work onto patients’ families. HealingMaps survey data

Read More

Spravato Has a Second Indication Most Clinics Never Market. Here Is What It Covers

Most clinics market Spravato for treatment-resistant depression only. A second FDA indication covers acute suicidal ideation, and the ASPIRE trials

Read More

Explore Psychedelic Therapy Regions